Northern Trust’s CalciMedica CALC Stock Holding History

Northern Trust’s Portfolio CALC Stock Details CALC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12.9K	Hold	2,506	–	–	﹤0.01%	4400
2026 Q1	$6.77K	Hold	2,506	–	–	﹤0.01%	4384
2025 Q4	$82.6K	Buy	+2,506	New	+$48.9K	﹤0.01%	4172
2023 Q1	–	Sell	-230	Closed	-$8.05K	–	4584
2022 Q4	$8.05K	Hold	230	–	–	﹤0.01%	4594
2022 Q3	$15K	Hold	230	–	–	﹤0.01%	4591
2022 Q2	$18K	Hold	230	–	–	﹤0.01%	4639
2022 Q1	$20K	Hold	230	–	–	﹤0.01%	4668
2021 Q4	$29K	Hold	230	–	–	﹤0.01%	4677
2021 Q3	$53K	Buy	230 +59	+35%	+$16.6K	﹤0.01%	4529
2021 Q2	$65K	Sell	171 -839	-83%	-$275K	﹤0.01%	4442
2021 Q1	$393K	Sell	1,010 -52	-5%	-$77.8K	﹤0.01%	3894
2020 Q4	$2.16M	Buy	+1,062	New	+$1.57M	﹤0.01%	3161

Other funds holding CALC

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

HCM

Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return

SCM

Squadron Capital Management Westmont, Illinois $322M AUM

Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

LGM

L1 Global Manager Melbourne $142M AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Northern Trust's CALC Position: Q2 2026 in Review

Northern Trust held its CalciMedica (CALC) position steady in Q2 2026 at 2,506 shares worth $12.9K. The position accounts for ﹤0.01% of the portfolio, ranked #4400.

Northern Trust first reported a position in CALC in Q4 2020 and has held it in 12 quarters since. The position peaked at $2.16M in Q4 2020. 31 funds tracked by Wall St. Rank hold CALC as of Q2 2026.

Northern Trust held 2,506 shares of CalciMedica worth $12.9K as of Q2 2026.
Northern Trust left its CalciMedica share count unchanged in Q2 2026.
CalciMedica made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #4400 holding.
Northern Trust first reported a position in CalciMedica in Q4 2020 and has held it in 12 quarters since.
Northern Trust's CalciMedica position peaked at $2.16M in Q4 2020.
31 funds tracked by Wall St. Rank held CalciMedica as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.